Objective-To demonstrate that Stargardt disease (STGD) can present with peripapillary atrophy.
uniquely spared from retinal and retinal pigment epithelium degeneration and its preservation is critical for visual function in patients with large central scotomas. 3, 4 In this case series, we reviewed 150 cases of STGD and describe three cases with peripapillary atrophy. We also report clinical findings from additional cases of STGD that share common ABCA4 mutations.
Methods
One hundred fifty consecutive STGD patients were identified and reviewed retrospectively for peripapillary atrophy from a STGD database from June 1999 to May 2007 at Columbia University Medical Center's Harkness Eye Institute. Two STGD patients without peripapillary atrophy who shared similar ABCA4 mutations as those with peripapillary atrophy were included in our case reports for comparison purposes.
Patients were enrolled with the approval of the Institutional Review Board (protocol #AAAB6560) at Columbia University. Genotyping was performed by the ABCR400 microarray 5 followed by direct sequencing to confirm identified variants.
Case Reports Case 1
A 55-year-old male was examined for long-standing central visual impairment since age 18. Family history was not significant for ocular disease. His best-corrected visual acuity of 20/350 OD and 20/200 OS was consistent with measurements over the last 20 years. Spherical refractive error measured −3.5 OD and −2.0 OS. Anterior segment examination was unremarkable and applanation tonometry measured 17 mmHg OD and 14 mmHg OS. Posterior segment examination and autofluorescence imaging were significant for sharply demarcated central and peripapillary zones of atrophy and the absence of fleck lesions ( Figure 1, A-D) . Humphrey visual fields demonstrated bilateral central scotomas with eccentric fixation at the inferior border. ERG examination was subnormal and similar to results obtained 22 years ago.
Genetic testing was employed for further diagnostic information and two heterozygous ABCA4 mutations, P1380L and IVS40 + 5G>A, were identified and classified as disease-causing alleles, thereby confirming the diagnosis of STGD.
Case 2
A 19-year-old female referred for consultation for difficulty reading, particularly in dim light. She was clinically diagnosed with STGD 3 month prior, after complaining of gradual difficulty in focusing. 
Case 3
A 15-year-old female presented with complaints of difficulty reading materials held greater than 6 inches from her eyes. She was clinically diagnosed with STGD 4 years prior and noted decreased visual acuity since age seven, which stabilized over the past few years. Family history was not significant for ocular disease. Best-corrected visual acuity was 20/150 OU. Anterior segment exam was unremarkable with applanation tonometry measuring 16 mmHg OU. Posterior segment exam and autofluorescence was significant for bilateral central atrophy and pisciform fleck atrophy involving the peripapillary, macular, and peripheral regions OU ( Figure 3, A and B) . Genotyping was significant for ABCA4 mutations P1380L and R2030Q.
Case 4
A 52-year-old male was examined for declining vision OS over the past few months. He was previously clinically diagnosed with STGD 7 years before presentation. Family history was not significant for ocular disease. Best-corrected visual acuity measured 20/100 OD and 20/70 OS. Spherical refractive error measured −3.00 OD and −3.25 OS. Anterior segment examination was unremarkable and applanation tonometry measured 17 mmHg OD and 14 mmHg OS. Posterior segment examination was significant for central atrophy and classic peripheral pisciform flecks sparing the peripapillary regions OU (Figure 4, A and B) . Autofluorescence imaging demonstrated inner atrophic flecks and outer hyperautofluorescent flecks. Moderate peripapillary hypoautofluorescence, but not atrophy, was present, likely secondary to the patient's myopia ( Figure 4 , C and D). Genotyping revealed two heterozygous ABCA4 mutations, P1380L and S1696N.
Case 5
A 46-year-old male was examined for visual acuity loss starting at age 17. His family history was significant for visual acuity loss by his brother and father during the second decade of life without known etiology. Genotype and phenotype data were not available. In addition, the patient's son was diagnosed with STGD with symptoms beginning at age 14. Best-corrected visual acuity measured 20/400 bilaterally. Anterior segment examination was unremarkable and applanation tonometry measured 12 mmHg OD and 13 mmHg OS. Posterior segment examination and autofluorescence imaging were significant for multifocal small atrophic lesions confined to the fovea OU and normal peripapillary regions ( Figure 5, A and B) . Genotyping revealed a single ABCA4 mutation, IVS40 + 5G>A, confirming the diagnosis of STGD. The patient's son was also examined and demonstrated classic STGD findings with peripapillary sparing. Genetic testing revealed a single ABCA4 mutation R1108C.
The pattern of inheritance between the father and son represents pseudo-dominant STGD. Both cases demonstrated classic STGD findings and a single identifiable mutation along with a nondetected ABCA4 mutation. The son received the nondetected mutation from the father and the identified mutation from the carrier mother, thereby accounting for the difference in genotype.
Discussion
In this series, we reviewed 150 consecutive cases of STGD and identified three cases with peripapillary atrophy (2.0%) ( Table 1) . Case 1 demonstrated peripapillary and central atrophy in a mildly myopic patient with ABCA4 mutations P1380L and IVS40 + 5G>A. Case 2 demonstrated atrophic fleck lesions involving the peripapillary region, central atrophy, and homozygous ABCA4 mutations P1380L and P1380L. Case 3 revealed bilateral central atrophy and pisciform fleck atrophy involving the peripapillary, macular, and peripheral regions with ABCA4 mutations P1380L and R2030Q.
Previous studies suggest that the peripapillary region is uniquely spared from retinal and retinal pigment epithelium degeneration. 3, 4 Our findings demonstrate that the clinical presentation of STGD is more variable than previously believed.
Peripapillary lesions may be attributable to specific combinations of ABCA4 mutations rather than single mutations. Many STGD cases with peripapillary preservation shared a common mutation with those cases with peripapillary atrophy. Overall, ABCA4 mutation P1380L was noted in 13 cases (8.7%), IVS40 + 5G>A in 6 cases (4.0%), and R2030Q in 1 case (0.7%). Cases 4 and 5 share common ABCA4 mutations with cases 1, 2, and 3 (P1380L or IVS40 + 5G>A), but did not yield findings of peripapillary atrophy. We were unable to find any previous reports in the literature of peripapillary atrophy in STGD, compound heterozygous ABCA4 mutations P1380L and IVS40 + 5G>A, clinical descriptions of homozygous mutations P1380L and P1380L, or clinical descriptions of compound heterozygous mutations P1380L and R2030Q.
This series also highlights the importance of genetic testing in clinical care. In Case 1, the clinical diagnosis was initially unclear and confounded by findings more consistent with choroidal sclerosis, 6 including peripapillary atrophy, coarse pigment clumping, and absence of the characteristic fleck atrophy of STGD. Genetic testing provided clarity and allowed for definitive diagnosis. 
